Background Depression affects around 280 million worldwide and one of the major unmet needs is the limited efficacy of t...
Vitamin B2: potential driver for cancer therapy
Cancer treatment has come a long way, but many therapies still struggle with targeting tumor cells without damaging heal...
Echoes of hope: DB-OTO gene therapy pioneers genetic hearing loss treatment DB-OTO Gene therapy: advancing treatment for genetic hearing loss
Regeneron Pharmaceuticals’ gene therapy, DB-OTO, has shown promising initial results in improving hearing for chil...
The Unified Patent Court: a historic turning point in the European patent landscape
The Unified Patent Court(“UPC”) became operational on 1 June 2023: it is a supranational court with exclusiv...
BionIT Labs closes a €5.5 million investment round with CDP Venture Capital Sgr, RIF Srl, Sefea Impact Sgr, SIMEST SpA, and Fondazione ENEA Tech e Biomedical
Investment goal: to make the Adam’s Hand bionic prosthesis the premier product in the American prosthetic market and t...
New Horizons in Type 1 Diabetes: FDA Approval of Lantidra and Emerging Therapies
The FDA has approved Lantidra, a groundbreaking donor-derived pancreatic islet cell therapy for type 1 diabetes, providi...